Accelerating Global Access

Our company is collaborating with a range of partners to enable access for patients around the world

At the outset of our research efforts for COVID-19, our company made clear its commitment to make any vaccine or medicine we develop for this pandemic broadly accessible.

Here’s how we have been working to fulfill that commitment.

What's your opinion of Merck & Co., Inc. after reading this?